Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Airway Epithelial Cells is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 3T32GM008361-30S1
Medical Scientist Training Program
National Institutes of Health
Grant: 5R35HL135816-04
Translational Program in CFTR-Related Airway Diseases
National Institutes of Health
Grant: 5F31HL146083-02
Mucus Matters: Mucociliary Physiology in Pulmonary Fibrosis
National Institutes of Health
Grant: 2T32HL105346-11A1
Training Program in Lung Biology and Translational Medicine
National Institutes of Health
Grant: 3P30DK072482-03S3
UAB CF Research and Translation Core Center
National Institutes of Health
Grant: 1ZIADK013039-04
Molecular modeling of soluble proteins
NIDDK NIH HHS
Grant: P30 DK072482
NHLBI NIH HHS
Grant: F31 HL146083
NHLBI NIH HHS
Grant: R35 HL135816
NHLBI NIH HHS
Grant: T32 HL105346
NIGMS NIH HHS
Grant: T32 GM008361
Fields of Study
Keywords
Sustainable Development Goals